The Pulse of New York Tech
Juventas is a provider and developer of innovative immune cell therapeutic drugs. Founded in 2018, Juventas is backed by CICC, CASI Pharmaceuticals, Dalton Venture, Panacea Venture, and Delian Capital and is headquartered in Chaoyang.
WRITE FOR US
NYC TECH EVENTS
NYC TECH NEWS
Join the millions and keep up with the stories shaping entrepreneurship. Sign up today.